Orphapacket:
  AverageAgeOfOnsets:
    AverageAgeOfOnset:
    - value: Adult
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
    value: Disease
  ExternalReferences:
  - DisorderMappingRelation: BTNT (ORPHAcode is broader than the targeted code used
      to represent it)
    Reference: '613024'
    Source: OMIM
  Genes:
  - Gene:
      DisorderGeneAssociationType: Part of a fusion gene in
      ExternalReferences:
      - Reference: BCL2
        Source: ClinVar
      - Reference: '990'
        Source: HGNC
      - Reference: '151430'
        Source: OMIM
      Name: BCL2 apoptosis regulator
      Symbol: BCL2
  - Gene:
      DisorderGeneAssociationType: Major susceptibility factor in
      ExternalReferences:
      - Reference: HLA-DRB1
        Source: ClinVar
      - Reference: '4948'
        Source: HGNC
      - Reference: '142857'
        Source: OMIM
      Name: major histocompatibility complex, class II, DR beta 1
      Symbol: HLA-DRB1
  - Gene:
      DisorderGeneAssociationType: Part of a fusion gene in
      ExternalReferences:
      - Reference: BCL6
        Source: ClinVar
      - Reference: '1001'
        Source: HGNC
      - Reference: '109565'
        Source: OMIM
      Name: BCL6 transcription repressor
      Symbol: BCL6
  - Gene:
      DisorderGeneAssociationType: Part of a fusion gene in
      ExternalReferences:
      - Reference: '146910'
        Source: OMIM
      - Reference: '147010'
        Source: OMIM
      - Reference: IGH@
        Source: ClinVar
      - Reference: '147070'
        Source: OMIM
      - Reference: '5477'
        Source: HGNC
      Name: immunoglobulin heavy locus
      Symbol: IGH
  Label: Follicular lymphoma
  ORPHAcode: '545'
  ORPHApacketId: '545'
  PURL: http://www.orpha.net/ORDO/Orphanet_545
  Parents:
  - Parent:
    - Label: Indolent B-cell non-Hodgkin lymphoma
      ORPHAcode: '300842'
  Phenotypes:
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0001824
      HPOTerm: Weight loss
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0001945
      HPOTerm: Fever
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002665
      HPOTerm: Lymphoma
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002716
      HPOTerm: Lymphadenopathy
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0100721
      HPOTerm: Mediastinal lymphadenopathy
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001744
      HPOTerm: Splenomegaly
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0012378
      HPOTerm: Fatigue
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0030166
      HPOTerm: Night sweats
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001004
      HPOTerm: Lymphedema
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001287
      HPOTerm: Meningitis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002202
      HPOTerm: Pleural effusion
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002585
      HPOTerm: Abnormality of the peritoneum
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0003072
      HPOTerm: Hypercalcemia
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0025435
      HPOTerm: Increased circulating lactate dehydrogenase concentration
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0030995
      HPOTerm: Peritoneal effusion
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0200036
      HPOTerm: Skin nodule
  - Phenotype:
      HPOFrequency: Very rare (<4-1%)
      HPOId: HP:0033823
      HPOTerm: Mediastinal mass
  Prevalences:
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: European Medicines Agency 2018[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: France
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: Institut National du Cancer 2013[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Bulgaria
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Estonia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Finland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Latvia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Lithuania
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Poland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Austria
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Belgium
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Croatia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Czech Republic
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Germany
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Iceland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Ireland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Italy
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Malta
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Norway
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Portugal
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Slovakia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Slovenia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Spain
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Switzerland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Netherlands
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  TextSection:
    Contents: Follicular lymphoma is a form of non-Hodgkin lymphoma characterized
      by a proliferation of B cells whose nodular structure of follicular architecture
      is preserved.
    TextSectionType: Definition
  TypeOfInheritances:
  - TypeOfInheritance:
      value: Multigenic/multifactorial
  - TypeOfInheritance:
      value: Not applicable
  copyright: Orphanet (c) 2025
  creationDate: '2025-06-26 11:48:15'
  version: 1.3.42 / 4.1.8 [2025-03-03]
